secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001628280-22-032552
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo Therapeutics expands ATM equity offering capacity by $175M to $325M total
--------------------------------------------------------------------------------

- Amendment No. 2 with Jefferies LLC adds $175M in common stock to existing at-the-market program.
- Prior to amendment, $115M of original $150M capacity had been sold.
- Remaining capacity under amended agreement is approximately $210M (based on $325M total less $115M sold).
- Terms and conditions of the Sales Agreement unchanged; shares sold at market prices under effective shelf registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000162828022032552/0001628280-22-032552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000162828022032552/sgmo-20221223.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-032552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer